Twenty years of Gendicine® rAd-p53 cancer gene therapy: The first-in-class human cancer gene therapy in the era of personalized oncology-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Twenty years of Gendicine® rAd-p53 cancer gene therapy: The first-in-class human cancer gene therapy in the era of personalized oncology

Published:2024-07 Issue:4 Volume:11 Page:101155
ISSN:2352-3042
Container-title:Genes & Diseases
language:en
Short-container-title:Genes & Diseases

Author:

Qi Li,Li Guiqing,Li Peipei^ORCID,Wang Hongwei,Fang Xiaolong^ORCID,He Tongchuan,Li Jingjing^ORCID

Publisher

Elsevier BV

Reference79 articles.

1. Blinded by the light: the growing complexity of p53;Vousden;Cell,2009

2. MDM4/HIPK2/p53 cytoplasmic assembly uncovers coordinated repression of molecules with anti-apoptotic activity during early DNA damage response;Mancini;Oncogene,2016

3. Therapeutic targeting of p53: all mutants are equal, but some mutants are more equal than others;Sabapathy;Nat Rev Clin Oncol,2018

4. TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes;Petitjean;Oncogene,2007

5. The IARC TP53 database: new online mutation analysis and recommendations to users;Olivier;Hum Mutat,2002

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of Drugs Targeting Mutant p53 and Progress in Nano-Enabled Therapeutic Strategy for p53-Mutated Cancers;Biomolecules;2025-05-26

2. Genetic engineering of primary human mesenchymal stromal cells using the CRISPR/Cas9 synergistic activation mediator;2025-05-12

3. Molecular Mechanisms in the Carcinogenesis of Oral Squamous Cell Carcinoma: A Literature Review;Biomolecules;2025-04-25

4. Nanotheranostics Revolutionizing Gene Therapy: Emerging Applications in Gene Delivery Enhancement;Journal of Nanotheranostics;2025-04-09

5. A Truncated Mutation of TP53 Promotes Chemoresistance in Tongue Squamous Cell Carcinoma;International Journal of Molecular Sciences;2025-03-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.7亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2025 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3